159 related articles for article (PubMed ID: 34861944)
21. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
22. Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance.
Menéndez-Arias L; Álvarez M; Pacheco B
Curr Opin Virol; 2014 Oct; 8():1-9. PubMed ID: 24814823
[TBL] [Abstract][Full Text] [Related]
23. Alpha-carboxynucleoside phosphonates: direct-acting inhibitors of viral DNA polymerases.
Balzarini J; Ford A; Maguire NM; John J; Das K; Arnold E; Dehaen W; Maguire A
Future Med Chem; 2019 Jan; 11(2):137-154. PubMed ID: 30648904
[TBL] [Abstract][Full Text] [Related]
24. Rational design of polymerase inhibitors as antiviral drugs.
Oberg B
Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225
[TBL] [Abstract][Full Text] [Related]
25. A standardized approach to the evaluation of antivirals against DNA viruses: Polyomaviruses and lymphotropic herpesviruses.
Keith KA; Hartline CB; Bowlin TL; Prichard MN
Antiviral Res; 2018 Nov; 159():122-129. PubMed ID: 30287227
[TBL] [Abstract][Full Text] [Related]
26. Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs.
Lim SE; Ponamarev MV; Longley MJ; Copeland WC
J Mol Biol; 2003 May; 329(1):45-57. PubMed ID: 12742017
[TBL] [Abstract][Full Text] [Related]
27. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
[TBL] [Abstract][Full Text] [Related]
28. Nucleosides and emerging viruses: A new story.
Roy V; Agrofoglio LA
Drug Discov Today; 2022 Jul; 27(7):1945-1953. PubMed ID: 35189369
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus.
Deval J; Symons JA; Beigelman L
Curr Opin Virol; 2014 Dec; 9():1-7. PubMed ID: 25194816
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
[TBL] [Abstract][Full Text] [Related]
31. Mutations conferring resistance to viral DNA polymerase inhibitors in camelpox virus give different drug-susceptibility profiles in vaccinia virus.
Duraffour S; Andrei G; Topalis D; Krečmerová M; Crance JM; Garin D; Snoeck R
J Virol; 2012 Jul; 86(13):7310-25. PubMed ID: 22532673
[TBL] [Abstract][Full Text] [Related]
32. An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness.
Trompet E; Temblador A; Gillemot S; Topalis D; Snoeck R; Andrei G
Viruses; 2021 May; 13(6):. PubMed ID: 34073189
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of foscarnet against viral polymerases.
Crumpacker CS
Am J Med; 1992 Feb; 92(2A):3S-7S. PubMed ID: 1371038
[TBL] [Abstract][Full Text] [Related]
34. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.
Piret J; Boivin G
Antimicrob Agents Chemother; 2011 Feb; 55(2):459-72. PubMed ID: 21078929
[TBL] [Abstract][Full Text] [Related]
35. [Not Available].
Agut H; Burrel S; Bonnafous P; Boutolleau D
Rev Prat; 2016 Nov; 66(9):1007-1014. PubMed ID: 30512372
[TBL] [Abstract][Full Text] [Related]
36. Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate.
Reid R; Mar EC; Huang ES; Topal MD
J Biol Chem; 1988 Mar; 263(8):3898-904. PubMed ID: 2831212
[TBL] [Abstract][Full Text] [Related]
37. Natural Products and Their Derivatives against Human Herpesvirus Infection.
Ruchawapol C; Yuan M; Wang SM; Fu WW; Xu HX
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684870
[TBL] [Abstract][Full Text] [Related]
38. Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.
Shannon A; Le NT; Selisko B; Eydoux C; Alvarez K; Guillemot JC; Decroly E; Peersen O; Ferron F; Canard B
Antiviral Res; 2020 Jun; 178():104793. PubMed ID: 32283108
[TBL] [Abstract][Full Text] [Related]
39. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
40. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
